A Biochemical Society Scientific Meeting
In recent years protein engineering has moved on significantly in terms of methods, targets and applications. While the utility of protein engineering means that it has been adapted throughout the life sciences by providing researchers with the means to interact and define the properties of their target protein, this is by no means the limit. By utilising recently developed methods, proteins are being constructed with no known equivalent in nature with new and useful emergent features (e.g. new catalytic mechanisms and oligomeric assemblies).
Synthetic biology has emerged as a critical new area of science which has adopted and applied many of the themes of protein engineering in new contexts. The self-assembly and functional properties of proteins are being increasingly engineered to function outside of their normal biological context. Protein engineering is also of increasing importance to commercial science, especially in terms of biopharmaceuticals (e.g. therapeutic antibodies), diagnostics, and biocatalysis (e.g. green solutions).
A conference dedicated to protein engineering will allow leading researchers from fundamental and applied labs, academic and commercial sectors to present the latest developments that may in turn be taken up by the science community.
What is covered?
- Methods: to include new computational design approaches, high-throughput mutagenesis and screening approaches (such as integrated microfluidics), genetic code expansion, and bionanotechnology (e.g. integration of biology with physical systems).
- Targets: to include application of new methods to traditional targets as well as exploring new protein targets including new protein scaffolds not present in nature, new biotherapeutics, and new catalysts/enzymes.
- Applications: to include new diagnostic and sensing platforms, use of proteins as components/devices in nanotechnology (e.g. protein devices and DNA sequencing) and synthetic biology, cell imaging/cell manipulation (including “switchable proteins”), new biocatalytic routes and genome engineering (e.g. engineered CRISPR-Cas).
For further information and to book, please visit the Biochemical Society website
Continuing Professional Development (CPD)
This event is approved by the Royal Society of Biology for purposes of CPD
and may be counted as 54 CPD credits